MedTrace Logo

Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain

NCT00647127 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2012-09-14

No results posted yet for this study

Summary

To compare the analgesic and anti-hyperalgesic effect of Buprenorphine and Fentanyl against experimental pain in skin, muscle and bone. The study will be performed with healthy volunteers.

Conditions

Interventions

DRUG

Buprenorphine

Buprenorphine: 20microg/h

DRUG

Fentanyl

Fentanyl: 25microg/h

DRUG

Placebo

Placebo: '5microg/h' (not active drug, it is just called '5microg/h')

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Asbjoern M Drewes, MD, Prof. · Mech Sense, Department of Gastroenterology, Aalborg Hospital

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-08-31
Completion
2010-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00647127 on ClinicalTrials.gov